Drug intelligence / Profile preview

Oxiracetam

Development stage
Unknown
Lead developer
CSPC Ouyi Pharmaceutical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Oxiracetam is a synthetic nootropic drug belonging to the racetam family, chemically derived from piracetam. It is recognized for its cognitive-enhancing properties, including improvements in memory, learning, and overall cognitive function. While its precise mechanism of action is still under research, it is believed to modulate both cholinergic and glutamatergic systems in the brain. Oxiracetam enhances the release and synthesis of acetylcholine, a neurotransmitter crucial for learning and memory, and interacts with glutamate receptors, particularly AMPA receptors, to facilitate synaptic transmission and plasticity. It also exhibits neuroprotective properties, influences brain energy metabolism by increasing ATP synthesis, and may increase levels of D-aspartic acid. Oxiracetam is not approved by the U.S. Food and Drug Administration for any medical use in the United States but is widely used as a dietary supplement and is being investigated for various cognitive impairments. Its (S)-enantiomer, L-oxiracetam, is considered the active ingredient and is also under clinical investigation.

Brand names
NeuractivHydroxypiracetamNeuracetam
Other names
4-Hydroxy-2-oxopyrrolidine-N-acetamide
02

Targets

AMPAR (AMPA receptor)PKC (Protein kinase C family)

Beyond the preview

Go deeper on Oxiracetam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxiracetam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call